scholarly journals Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

Author(s):  
Joseph S. Baxter ◽  
Nichola Johnson ◽  
Katarzyna Tomczyk ◽  
Andrea Gillespie ◽  
Sarah Maguire ◽  
...  
Author(s):  
Dylan M. Glubb ◽  
Wei Shi ◽  
Jonathan Beesley ◽  
Laura Fachal ◽  
Jayne-Louise Pritchard ◽  
...  

Genome-wide association studies have revealed a locus at 8p12 that is associated with breast cancer risk. Fine-mapping of this locus identified 16 candidate causal variants (CCVs). However, as these variants are intergenic, their function is unclear. To map chromatin looping from this risk locus to a previously identified candidate target gene, DUSP4, we performed chromatin conformation capture analyses in normal and tumoral breast cell lines. We identified putative regulatory elements, containing CCVs, that loop to the DUSP4 promoter region. Using reporter gene assays, we found that the risk allele of CCV rs7461885 reduced the activity of a DUSP4 enhancer element, consistent with the function of DUSP4 as a tumor suppressor gene. Furthermore, the risk allele of CCV rs12155535, located in another DUSP4 enhancer element, was negatively correlated with looping of this element to the DUSP4 promoter region, suggesting that this allele would be associated with reduced expression. These findings provide the first evidence that CCV risk alleles downregulate DUSP4 expression, suggesting that this gene is a regulatory target of the 8p12 breast cancer risk locus.


Cancers ◽  
2020 ◽  
Vol 12 (1) ◽  
pp. 170
Author(s):  
Dylan M. Glubb ◽  
Wei Shi ◽  
Jonathan Beesley ◽  
Laura Fachal ◽  
Jayne-Louise Pritchard ◽  
...  

Genome-wide association studies have revealed a locus at 8p12 that is associated with breast cancer risk. Fine-mapping of this locus identified 16 candidate causal variants (CCVs). However, as these variants are intergenic, their function is unclear. To map chromatin looping from this risk locus to a previously identified candidate target gene, DUSP4, we performed chromatin conformation capture analyses in normal and tumoural breast cell lines. We identified putative regulatory elements, containing CCVs, which looped to the DUSP4 promoter region. Using reporter gene assays, we found that the risk allele of CCV rs7461885 reduced the activity of a DUSP4 enhancer element, consistent with the function of DUSP4 as a tumour suppressor gene. Furthermore, the risk allele of CCV rs12155535, located in another DUSP4 enhancer element, was negatively correlated with looping of this element to the DUSP4 promoter region, suggesting that this allele would be associated with reduced expression. These findings provide the first evidence that CCV risk alleles downregulate DUSP4 expression, suggesting that this gene is a regulatory target of the 8p12 breast cancer risk locus.


2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Wen-Ke Cai ◽  
Jia-Bin Zhang ◽  
Niu-Min Wang ◽  
Ying-Lin Wang ◽  
Can-Hu Zhao ◽  
...  

Histamine H2receptor (HRH2) was previously suggested to affect the proliferation of breast cancer cells and disease-free survival of breast cancer patients. Furthermore, a common polymorphism, rs2067474, was identified in an enhancer element of theHRH2gene promoter and was reported to be associated with various diseases including cancer. However, the relationship between this polymorphism and breast cancer risk and malignant degree remains unclear. The aim of this study was to clarify the clinical association of rs2067474 polymorphism with breast cancer. A total of 201 unrelated Chinese Han breast cancer patients and 238 ethnicity-matched health controls were recruited and rs2067474 polymorphism was genotyped. Logistic regression analyses were performed to calculate the odds ratios (ORs) as a measure of association of genotype with breast cancer according to 3 genetic models (dominant, recessive, and additive). Although the percentage of hormone receptor negative cases tended to be higher in AA genotypes, we did not find any significant associations of rs2067474 polymorphism with breast cancer risk or with related clinicopathological parameters in the present study, which indicates that rs2067474 polymorphism ofHRH2gene might not be a risk factor in the development of breast cancer in Chinese Han population.


2013 ◽  
Vol 93 (6) ◽  
pp. 1046-1060 ◽  
Author(s):  
Kerstin B. Meyer ◽  
Martin O’Reilly ◽  
Kyriaki Michailidou ◽  
Saskia Carlebur ◽  
Stacey L. Edwards ◽  
...  

2015 ◽  
Vol 97 (1) ◽  
pp. 22-34 ◽  
Author(s):  
Hatef Darabi ◽  
Karen McCue ◽  
Jonathan Beesley ◽  
Kyriaki Michailidou ◽  
Silje Nord ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (5) ◽  
pp. e63925 ◽  
Author(s):  
Suhn Kyong Rhie ◽  
Simon G. Coetzee ◽  
Houtan Noushmehr ◽  
Chunli Yan ◽  
Jae Mun Kim ◽  
...  

2021 ◽  
Vol 132 ◽  
pp. S38-S39
Author(s):  
Saeideh Torabi Dalivandan ◽  
Stephanie Chen ◽  
Felipe Dezem ◽  
Brian Davis ◽  
Justyna Kanska ◽  
...  

2016 ◽  
Vol 76 (7) ◽  
pp. 1916-1925 ◽  
Author(s):  
Nicola J. Camp ◽  
Wei-Yu Lin ◽  
Alex Bigelow ◽  
George J. Burghel ◽  
Timothy L. Mosbruger ◽  
...  

2015 ◽  
Vol 37 (2) ◽  
pp. 163-168 ◽  
Author(s):  
Yaqiong Sun ◽  
Chuanzhong Ye ◽  
Xingyi Guo ◽  
Wanqing Wen ◽  
Jirong Long ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document